Synapsin I Protein

Synapsin I Protein

Introduction

Synapsin I Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@supa2017]
<table> [@supa2010]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synapsin I</th></tr> [@supa2017a]
<tr><td><strong>Protein Name</strong></td><td>Synapsin I</td></tr> [@supa2018]
<tr><td><strong>Gene</strong></td><td><a href="/genes/syn1">SYN1</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P17600">P17600</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>1A7I</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>80 kDa</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Synaptic vesicle</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Synapsin family</td></tr>
</table>
</div>

Overview

Synapsin I Protein

Introduction

Synapsin I Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@supa2017]
<table> [@supa2010]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synapsin I</th></tr> [@supa2017a]
<tr><td><strong>Protein Name</strong></td><td>Synapsin I</td></tr> [@supa2018]
<tr><td><strong>Gene</strong></td><td><a href="/genes/syn1">SYN1</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P17600">P17600</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>1A7I</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>80 kDa</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Synaptic vesicle</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Synapsin family</td></tr>
</table>
</div>

Overview

Synapsin I is a neuronal phosphoprotein that plays a fundamental role in regulating synaptic vesicle trafficking, neurotransmitter release, and synaptic plasticity. Encoded by the SYN1 gene, Synapsin I is one of the most abundant proteins associated with synaptic vesicles in presynaptic terminals, where it functions as a critical link between the synaptic vesicle membrane and the actin cytoskeleton. Originally discovered in the 1970s as a major substrate for cAMP-dependent protein kinase (PKA), Synapsin I has since been recognized as a master regulator of the synaptic vesicle cycle, controlling vesicle availability, release probability, and activity-dependent modulation of neurotransmission[@supa2015].

Beyond its essential role in normal synaptic function, Synapsin I has been implicated in various neurodegenerative and neuropsychiatric disorders. Epilepsy-associated mutations in SYN1 disrupt synaptic vesicle dynamics and contribute to seizure susceptibility. In Alzheimer's disease (AD), Synapsin I levels are altered in brain regions affected by amyloid pathology, and the protein interacts with [amyloid-beta](/proteins/amyloid-beta) peptide to modulate synaptic toxicity. Parkinson's disease (PD) and other movement disorders also show Synapsin I abnormalities, reflecting the broader disruption of synaptic homeostasis in these conditions[@supa2017].

Structure

Synapsin I is a member of the synapsin family (along with Synapsin II and III), which share conserved domains but exhibit distinct expression patterns and functional properties. The protein contains multiple functional domains:

Domain Organization

Phosphorylation Sites

Synapsin I is one of the most heavily phosphorylated neuronal proteins, with multiple sites regulated by distinct kinases:

• Ser9: Phosphorylated by PKA (cAMP-dependent protein kinase)
• Ser62, Ser67: Phosphorylated by CaMKII (Ca2+/calmodulin-dependent protein kinase II)
• Ser549, Ser551: Phosphorylated by MAPK/ERK
• Ser4, Ser10: Phosphorylated by [CDK5](/proteins/cdk5)

Molecular Function

Synaptic Vesicle Clustering

In resting [neurons](/entities/neurons), Synapsin I binds to synaptic vesicles through its N-terminal domain and cross-links them into a reserve pool tethered to the actin cytoskeleton. This clustering maintains a readily releasable pool (RRP) of synaptic vesicles while preventing their premature fusion. The protein's ability to dimerize through its C-terminal domain further stabilizes the vesicle cluster.

Regulation of Neurotransmitter Release

Upon neuronal stimulation, calcium influx activates CaMKII, which phosphorylates Synapsin I at Ser62 and Ser67. This phosphorylation reduces Synapsin I's affinity for actin and synaptic vesicles, releasing the bound vesicles from the reserve pool and making them available for fusion at the active zone. This mechanism links synaptic activity to the recruitment of vesicles from the reserve pool, a process essential for sustained neurotransmission[@supa2017a].

The functional outcomes of Synapsin I activity include:

Interactions with the Cytoskeleton

Synapsin I interacts with both actin filaments and microtubules, serving as a bridge between synaptic vesicles and the cytoskeletal network. This interaction is regulated by phosphorylation state, with dephosphorylated Synapsin I showing higher affinity for actin.

Role in Neurodegenerative Diseases

Alzheimer's Disease

Synapsin I is prominently affected in Alzheimer's disease through multiple mechanisms:

Parkinson's Disease

In PD, Synapsin I alterations contribute to dopaminergic transmission deficits:

• Reduced Synapsin I levels in substantia nigra pars compacta dopaminergic neurons
• Interaction with [alpha-synuclein](/proteins/alpha-synuclein): α-Syn can co-aggregate with Synapsin I, potentially disrupting vesicle function
• L-DOPA-induced dyskinesia: Altered Synapsin I phosphorylation may contribute to abnormal motor responses

Epilepsy

SYN1 mutations are causally linked to epilepsy:

• Missense mutations disrupt synaptic vesicle clustering
• Truncation mutations cause loss of function
• Synapsin I deficiency leads to increased seizure susceptibility in mouse models

Other Disorders

• Autism Spectrum Disorder: SYN1 mutations identified in ASD patients
• Schizophrenia: Altered Synapsin I expression in postmortem brain
• Huntington's Disease: Synapsin I dysfunction contributes to striatal synaptic deficits

Mutations and Genetic Variants

Pathogenic SYN1 variants include:

• Missense mutations: R233G, R420C, L381P - disrupt vesicle binding
• Truncation mutations: Q555X, R607X - cause loss of function
• Splice site mutations: Affect alternative splicing of domain C

Therapeutic Implications

Drug Development Targets

Gene Therapy

Viral vector-mediated SYN1 delivery is being explored for:

• Neuroprotection in AD
• Restoration of synaptic function in PD
• Treatment of epilepsy

Animal Models

Synapsin I knockout mice exhibit:

• Reduced seizure threshold
• Impaired synaptic plasticity
• Abnormal vesicle pool dynamics
• Compensatory upregulation of Synapsin II

See Also

• [Synaptic Transmission](/mechanisms/synaptic-transmission)
• [SYN1 Gene](/genes/syn1)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Vesicles](/mechanisms/synaptic-vesicle-cycling)

Background

The study of Synapsin I Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

PMID: 25916578(https://pubmed.ncbi.nlm.nih.gov/25916578/) PMID: 28793359(https://pubmed.ncbi.nlm.nih.gov/28793359/) PMID: 24617921(https://pubmed.ncbi.nlm.nih.gov/24617921/) PMID: 21447621(https://pubmed.ncbi.nlm.nih.gov/21447621/) PMID: 28793359(https://pubmed.ncbi.nlm.nih.gov/28793359/)